Clinical Trial Update: mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating the addition of radiotherapy to the modified FOLFIRINOX chemotherapy regimen in CA19-9-normal advanced pancreatic cancer is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• mFOLFIRINOX

Snippet

Sponsor: Fudan University | Conditions: Pancreatic Adenocarcinoma | Phase 2 | Status: RECRUITING